Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

LENSAR, Inc.

LNSRNASDAQ
Healthcare
Medical - Devices
$11.69
$0.00(0.00%)
U.S. Market opens in 16h 27m

LENSAR, Inc. Fundamental Analysis

LENSAR, Inc. (LNSR) shows moderate financial fundamentals with a PE ratio of -2.77, profit margin of -87.12%, and ROE of 5.33%. The company generates $0.1B in annual revenue with strong year-over-year growth of 26.87%.

Key Strengths

Cash Position11.98%
PEG Ratio0.65

Areas of Concern

ROE5.33%
Operating Margin-35.42%
We analyze LNSR's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -12.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-12.9/100

We analyze LNSR's fundamental strength across five key dimensions:

Efficiency Score

Weak

LNSR struggles to generate sufficient returns from assets.

ROA > 10%
-73.39%

Valuation Score

Excellent

LNSR trades at attractive valuation levels.

PE < 25
-2.77
PEG Ratio < 2
0.65

Growth Score

Moderate

LNSR shows steady but slowing expansion.

Revenue Growth > 5%
26.87%
EPS Growth > 10%
-1.08%

Financial Health Score

Excellent

LNSR maintains a strong and stable balance sheet.

Debt/Equity < 1
-0.24
Current Ratio > 1
1.24

Profitability Score

Weak

LNSR struggles to sustain strong margins.

ROE > 15%
5.33%
Net Margin ≥ 15%
-87.12%
Positive Free Cash Flow
No

Key Financial Metrics

Is LNSR Expensive or Cheap?

P/E Ratio

LNSR trades at -2.77 times earnings. This suggests potential undervaluation.

-2.77

PEG Ratio

When adjusting for growth, LNSR's PEG of 0.65 indicates potential undervaluation.

0.65

Price to Book

The market values LENSAR, Inc. at -11.79 times its book value. This may indicate undervaluation.

-11.79

EV/EBITDA

Enterprise value stands at -11.59 times EBITDA. This is generally considered low.

-11.59

How Well Does LNSR Make Money?

Net Profit Margin

For every $100 in sales, LENSAR, Inc. keeps $-87.12 as profit after all expenses.

-87.12%

Operating Margin

Core operations generate -35.42 in profit for every $100 in revenue, before interest and taxes.

-35.42%

ROE

Management delivers $5.33 in profit for every $100 of shareholder equity.

5.33%

ROA

LENSAR, Inc. generates $-73.39 in profit for every $100 in assets, demonstrating efficient asset deployment.

-73.39%

Following the Money - Real Cash Generation

Operating Cash Flow

LENSAR, Inc. generates limited operating cash flow of $-11.69M, signaling weaker underlying cash strength.

$-11.69M

Free Cash Flow

LENSAR, Inc. generates weak or negative free cash flow of $-11.78M, restricting financial flexibility.

$-11.78M

FCF Per Share

Each share generates $-0.99 in free cash annually.

$-0.99

FCF Yield

LNSR converts -8.50% of its market value into free cash.

-8.50%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-2.77

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.65

vs 25 benchmark

P/B Ratio

Price to book value ratio

-11.79

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.40

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-0.24

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.24

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

5.33

vs 25 benchmark

ROA

Return on assets percentage

-0.73

vs 25 benchmark

ROCE

Return on capital employed

-0.61

vs 25 benchmark

How LNSR Stacks Against Its Sector Peers

MetricLNSR ValueSector AveragePerformance
P/E Ratio-2.7729.43 Better (Cheaper)
ROE532.96%800.00% Weak
Net Margin-87.12%-20145.00% (disorted) Weak
Debt/Equity-0.240.30 Strong (Low Leverage)
Current Ratio1.244.64 Neutral
ROA-73.39%-17936.00% (disorted) Weak

LNSR outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews LENSAR, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

61.85%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-97.90%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

83.31%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ